Question 1

Does Wealthspire Advisors own REGN stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Wealthspire Advisors holds 7,042 shares of REGN (Regeneron Pharmaceuticals), worth $4.4M.

Question 2

How many shares of REGN does Wealthspire Advisors own?

Accepted Answer

As of its Q2 2026 13F, Wealthspire Advisors holds 7,042 shares of REGN (Regeneron Pharmaceuticals).

Question 3

What is Wealthspire Advisors' REGN position worth?

Accepted Answer

As of its Q2 2026 13F, Wealthspire Advisors' REGN position is worth $4.4M.

Question 4

Is Wealthspire Advisors buying or selling REGN?

Accepted Answer

In Q2 2026, Wealthspire Advisors reduced its REGN position by 1,664 shares (-19.1%).

Question 5

When did Wealthspire Advisors first buy REGN?

Accepted Answer

Wealthspire Advisors first reported REGN in its Q3 2019 13F and has listed it in 22 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	7,042	-19.1%	$4.4M	0.0%	$622.81	0
2026-Q1	Increased	8,706	+168.5%	$6.7M	0.1%	$770.59	44
2025-Q4	Increased	3,243	+8.7%	$2.5M	0.0%	$768.90	28
2025-Q3	Decreased	2,984	-51.4%	$1.7M	0.0%	$559.40	0
2025-Q2	Decreased	6,137	-34.4%	$3.2M	0.0%	$521.53	0
2025-Q1	Increased	9,350	+66.4%	$5.9M	0.0%	$629.11	40
2024-Q4	Decreased	5,619	-30.7%	$4M	0.0%	$705.67	0
2024-Q3	Increased	8,112	+1629.6%	$8.5M	0.1%	$1,041.41	44